Foshan, China, July 9, 2025 - Dahao Medical, a pioneering manufacturer specializing in China transfer chairs, nursing care beds, and rehabilitation equipment, recently welcomed a delegation of district leaders for an in-depth investigation into the company's technological innovations and production capabilities. The visit highlighted Dahao Medical's commitment to advancing high-quality medical technology solutions that address critical needs in elderly care, post-surgical rehabilitation, and disability support.
1. Government Recognition of Medical Innovation
The investigation team, comprising officials from the District People's Congress and Economic Promotion Bureau, toured Dahao Medical's state-of-the-art production facilities and R&D center. Chairman Huang Zehui and Deputy General Manager Jiang Jinliang presented the company's latest breakthroughs in patient mobility solutions and intelligent nursing care systems.
Key discussion points included:
• Policy Alignment: How Dahao Medical's China transfer chairs and electric nursing care beds support national healthcare initiatives like "Healthy China 2030" and elderly care development plans.
• Export Competitiveness: The delegation praised Dahao's CE-certified transfer chairs and FDA-registered nursing beds, which meet international standards for safety and ergonomics.
"Dahao Medical's focus on user-centric design and technological innovation sets a benchmark for the industry. Their nursing care beds with AI-powered pressure relief demonstrate how smart technology can enhance patient comfort and reduce caregiver strain," remarked a district official during the visit.
2. Spotlight on Core Innovations: Elevating Care Standards
(A) China Transfer Chairs: Safe and Efficient Patient Handling
Dahao Medical's 0776-Series Transfer Chairs are engineered to improve safety and efficiency in hospitals and nursing homes:
• Ergonomic Design: Weight-distribution technology minimizes fall risks during patient transfers.
• Hybrid Mobility: Manual-to-electric convertible models for versatile use in different care settings.
• Anti-Microbial Materials: Silver-ion coated surfaces inhibit bacterial growth, crucial for infection control.
Clinical Impact: Partner hospitals report 35% fewer staff injuries and 28% faster transfer times after adopting Dahao's solutions.
(B) Smart Nursing Care Beds: Redefining Long-Term Care
The M-Series Intelligent Nursing Beds integrate cutting-edge features:
• Multi-Position Adjustability: Electric backrest/leg rest adjustments with memory presets.
• Pressure Ulcer Prevention: Real-time body pressure mapping with automatic adjustment alerts.
• Remote Monitoring: IoT-enabled beds transmit vital signs to caregivers' dashboards.
Market Context: With China's aged care bed gap exceeding 5 million units, Dahao's scalable production addresses urgent societal needs.
3. Manufacturing Excellence: Precision Meets Compassion
The delegation observed:
• Robotic Assembly Lines: Automated welding for ultra-stable bed frames (tested to 500kg+ capacity).
• Lean Production: 72-hour order-to-shipment turnaround for standard nursing beds.
• Local Collaboration: 50+ Guangdong-based suppliers form an integrated supply chain.
4. Strategic Growth Plans
Daho Medical unveiled ambitious initiatives to:
• Triple production capacity for bariatric transfer chairs by 2025, responding to obesity epidemic challenges.
• Launch a tele-rehabilitation platform connecting nursing beds with physiotherapists via 5G.
• Establish ASEAN Training Centers to educate caregivers on optimal equipment use.
5. Leadership Perspectives
"This investigation reinforces our mission to fuse German engineering standards with China's manufacturing scale," stated Chairman Huang. "Our upcoming collaboration with Johns Hopkins University on fall-prevention algorithms will further distinguish Dahao's transfer chairs in global markets."
6. Conclusion: A Vision for the Future
The visit culminated in a roundtable on standard-setting for medical device cybersecurity, positioning Dahao Medical at the forefront of smart healthcare infrastructure. With government support, the company aims to capture 15% of Asia's premium nursing bed market by 2026.
